Clinical Trial Update: Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial investigating rosuvastatin in patients with surgically removed stage I/II colorectal cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Colorectal Cancer, Precancerous Condition | Phase 3 | Status: TERMINATED | Results posted: 2023-08-16